Early advance care planning education for young adults with advanced solid tumors or high-grade brain tumors
Official title: Empowerment Through Preparedness: Improving Advance Care Planning (ACP) in Adolescents and Young Adults (AYAs) With Advanced Solid Malignancies and High-Grade Brain Tumors
Run by Mayo Clinic · NCT07174661 · Data updated 2026-11-12
This project will test whether short educational tools help adolescents and young adults (diagnosed at 18–39) with advanced solid tumors or high-grade brain tumors start advance care planning earlier.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 39 Years |
| Sex | All |
| Enrollment | 50 (estimated) |
| Sponsor | Mayo Clinic Academic / other |
| Locations | 1 site (Scottsdale, Arizona) |
| Status | Recruiting |
| Started | September 2, 2025 |
| Main results expected | June 30, 2027 |
| Study ends | June 30, 2027 |
| Registry record updated | July 8, 2026 |
| Trial ID | NCT07174661 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are English-speaking patients diagnosed at ages 18–39 within the last 12 months (or with an advanced relapse) with stage III/IV solid tumors or high-grade brain tumors who receive primary oncology care at Mayo Clinic in Arizona.
✕Probably not a fit
Patients diagnosed more than 12 months ago, those with stage I/II solid tumors, low-grade brain tumors, hematologic malignancies, non-English speakers, pediatric patients, or anyone not receiving primary oncology care at Mayo Clinic Arizona are not eligible and likely would not benefit from this intervention.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This interventional pilot uses brief educational tools—including an early ACP video featuring AYA voices—plus surveys and electronic health record review to encourage timely advance care planning. Eligible participants are patients diagnosed at ages 18–39 within the past 12 months (or with an advanced-stage relapse) who have stage III/IV solid tumors or high-grade brain tumors and receive primary oncology care at Mayo Clinic in Arizona. The study measures whether participants have ACP conversations, document advance directives, and show changes on survey measures after the educational intervention. Data will be collected through patient surveys and chart review to compare ACP uptake before and after the intervention.
Why it matters
Potential benefit: If successful, the tools could increase early ACP conversations and advance directive completion so care better matches young adults' preferences.
How similar studies have gone: Prior ACP education studies in adults have improved documentation and conversations, but focused AYA interventions are limited and this video-based approach is relatively novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age 18-39 at initial cancer diagnosis * Patient \<18 years of age are not included in this pilot as Mayo Clinic in Arizona (MCA) does not treat pediatric patients * Recently diagnosed (defined as 12 months or less from initial diagnosis or advance stage relapse) with either a stage III/IV solid malignancy or high-grade brain tumor. This includes patients who have stage III/IV recurrence of previously stage I/II solid malignancy * Actively receiving primary oncologic care at Mayo Clinic Arizona * Able to read, understand, and speak English * Those who have completed prior advanced directive documents are still eligible to participate. Exclusion Criteria: * Age \< 18 or \> 39 at initial cancer diagnosis * Diagnosed with stage I/II solid malignancy, low-grade brain tumor, or hematologic malignancy * Not receiving primary oncologic care at Mayo Clinic Arizona * Unable to read, understand, and speak English * Patients \> 12 months from initial diagnosis or advanced stage relapses, in survivorship or on hospice * No internet or computer/smart phone access
Where it's running
-
Mayo Clinic in Arizona
Scottsdale, Arizona, United States Recruiting
Study contacts
- Principal investigator: Allison C. Rosenthal, DO — Mayo Clinic
- Study coordinator: Sey Oloyede
- Email: oloyede.oluwaseyitan@mayo.edu
- Phone: 507-538-6811
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Morning versus afternoon immunotherapy for advanced or metastatic solid tumors
This trial tests whether giving standard immune checkpoint inhibitor therapy in the morning versus the afternoon changes outcomes for adults with advanced or metastatic solid tumors.
-
Advanced MRI to distinguish recurrent brain tumor from radiation necrosis
This trial tests whether advanced MRI scans (DR-CSI and sodium imaging) can tell if people with metastatic brain tumors have tumor recurrence or treatment-related radiation necrosis.
-
TR-002 (Nadofaragene Firadenovec) given by IV for adults with advanced unresectable or metastatic solid tumors and refractory metastatic pancreatic adenocarcinoma
This Phase 1 trial tests whether weekly intravenous TR-002 is safe and what dose is best for adults with advanced unresectable or metastatic solid tumors or refractory metastatic pancreatic cancer.
-
Telephone coaching to help people with advanced cancer and their support person plan for end-of-life care
This program tests whether two phone coaching sessions help people with advanced cancer and their support person have end-of-life conversations and complete advance directives.
-
Breathing practice to improve brain and mental health in cancer and MS patients
This study tests whether breathing exercises through a mobile app can help improve brain and mental health for people with cancer and multiple sclerosis, along with their caregivers.
-
18F-DOPA PET/CT to guide care for adults with brain tumors
This test tries whether adding 18F-DOPA PET/CT scans to standard imaging helps doctors manage care for adults with malignant brain tumors.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.